MoneyWorks4Me

Cohance Lifesciences - Quaterly Results

06 Aug 2026 Evaluate
Net sales declined -25.58%  to  Rs. 3598.90 million from Rs. 4835.80 millions.Net profit was down at Rs. 14.10  millions against Rs. 525.70 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -97.32%.Operating Profit reported a sharp decline to 386.50 millions from 1173.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 3598.90 4835.80 -25.58 3598.90 4835.80 -25.58 20305.00 25044.30 -18.92
Other Income 121.60 131.00 -7.18 121.60 131.00 -7.18 447.30 648.40 -31.01
PBIDT 386.50 1173.00 -67.05 386.50 1173.00 -67.05 4991.40 8490.50 -41.21
Interest 21.20 68.00 -68.82 21.20 68.00 -68.82 224.60 367.00 -38.80
PBDT 365.30 1024.00 -64.33 365.30 1024.00 -64.33 4472.10 7965.70 -43.86
Depreciation 343.20 313.60 9.44 343.20 313.60 9.44 1335.80 1465.10 -8.83
PBT 22.10 710.40 -96.89 22.10 710.40 -96.89 3136.30 6500.60 -51.75
TAX 8.00 184.70 -95.67 8.00 184.70 -95.67 849.20 1588.80 -46.55
Deferred Tax 8.00 3.20 150.00 8.00 3.20 150.00 68.20 -124.30 -154.87
PAT 14.10 525.70 -97.32 14.10 525.70 -97.32 2287.10 4911.80 -53.44
Equity 382.60 382.60 0.00 382.60 382.60 0.00 382.60 254.60 50.27
PBIDTM(%) 10.74 24.26 -55.73 10.74 24.26 -55.73 24.58 33.90 -27.49

Cohance Lifesciences Share Price

445.70 5.85 (1.33%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: